Atherosclerosis 151 (2000) 601 – 603
Author index
Volume 151 (2000)
www.elsevier.com/locate/atherosclerosis
(MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice 151, 593
Faglia, G., see Arosio, M. 151, 551
Ferns, G.A.A., see Williams, J.C. 151, 463
Fisicaro, M., see Baldassarre, D. 151, 575 Forster, L.A., see Williams, J.C. 151, 463 Fotherby, M.D., see Williams, J.C. 151, 463
Frants, R.R., see Hoffer, M.J.V. 151, 443
Friedlander, Y., see Kark, J.D. 151, 509
Gallus, G., see Baldassarre, D. 151, 575
Gobbi, C., see Baldassarre, D. 151, 575
Goto, Y., see Kojima, S. 151, 585
Grieve, D.J., M.A. Avella, K.M. Botham, J. Elliott, Chylomicron remnants potentiate phenylephrine-induced contractions of rat aorta by an endothelium-dependent mechanism 151, 471
Grimsditch, D.C., S. Penfold, J. Latcham, M. Vidgeon-Hart, P.H.E. Groot, G.M. Benson, C3H apoE(− / −) mice have less atherosclerosis than C57BL apoE(− / −) mice despite having a more atherogenic serum lipid profile 151, 389
Groot, P.H.E., see Grimsditch, D.C. 151, 389
Gylling, H., see Lindbohm, N. 151, 545 Heikkinen, J., see Karjalainen, A. 151, 559
Heinonen, O., see Vasankari, T. 151, 399
Heinz, G., see Schmaldienst, S. 151, 493
Hoffer, M.J.V., H. Snieder, S.J.H. Bredie, P.N.M. Demacker, J.J.P. Kastelein, R.R. Frants, A.F.H. Stalenhoef, The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia 151, 443
Horie, H., see Kojima, S. 151, 585
Ho¨rl, W.H., see Schmaldienst, S. 151, 493
Hsieh, C.-C., M.-H. Yen, H.-W. Liu, Y.-T. Lau, Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL 151, 481
Hultberg, B., see Andersson, A. 151, 535 Hultberg, B., see Nielsen, N.E. 151, 423
Huuskonen, J., M. Ekstro¨m, E. Tahvanainen, A. Vainio, J. Metso, P. Pussinen, C. Ehnholm, V.M. Olkkonen, M. Jauhiainen, Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity 151, 451
Irjala, K., see Vasankari, T. 151, 399
Ishizaki, M., P. Martikainen, H. Nakagawa, M. Marmot, The relationship between employment grade and plasma fibrinogen level among Japanese male employees 151, 415
Iwai, N., see Kojima, S. 151, 585
Ahotupa, M., see Vasankari, T. 151, 399
Aizienie`ne, L., see Kristenson, M. 151, 501
Andersson, A., B. Hultberg, A. Lindgren, Redox status of plasma homocysteine and other plasma thiols in stroke patients 151, 535
Arnett, D.K., see Tsai, M.Y. 151, 519
Arosio, M., G. Sartore, C.M. Rossi, G. Casati, G. Faglia, E. Manzato, LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy 151, 551
Auwerx, J., see Pihlajama¨ki, J. 151, 567
Avella, M.A., see Grieve, D.J. 151, 471
Ba¨ckstro¨m, A.-C., see Karjalainen, A. 151, 559
Baldassarre, D., F. Veglia, C. Gobbi, G. Gallus, A. Ventura, G. Crepaldi, M. Fisicaro, S. Rimondi, G. Ricci, M. Mancini, M.G. Bond, S. Collatina, C.R. Sirtori, Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: the carotid atherosclerosis Italian ultrasound study 151, 575
Banyai, S., see Schmaldienst, S. 151, 493
Barnard, J.R., see Sun, Z. 151, 381
Belgore, F.M., G.Y.H. Lip, A.D. Blann, Successful therapy reduces levels of vascular endothelial growth factor (VEGF) in patients with hypertension and patients with hypercholesterolemia 151, 599
Benson, G.M., see Grimsditch, D.C. 151, 389
Bergdahl, B., see Kristenson, M. 151, 501
Beyzade, S., see Dunleavey, L. 151, 587
Blann, A.D., see Belgore, F.M. 151, 599
Bobik, A., see Ward, M.R. 151, 407
Bond, M.G., see Baldassarre, D. 151, 575
Botham, K.M., see Grieve, D.J. 151, 471
Bo, Z., see Kristenson, M. 151, 501 Brattstro¨m, L., see Nielsen, N.E. 151, 423 Bredie, S.J.H., see Hoffer, M.J.V. 151, 443 Casati, G., see Arosio, M. 151, 551 Collatina, S., see Baldassarre, D. 151, 575 Crepaldi, G., see Baldassarre, D. 151, 575 Deeb, S., see Pihlajama¨ki, J. 151, 567
Demacker, P.N.M., see Hoffer, M.J.V. 151, 443 Derfler, K., see Schmaldienst, S. 151, 493
Dunleavey, L., S. Beyzade, S. Ye, Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism 151, 587
Eckardstein, A., see Eue, I. 151, 593
Eckfeldt, J.H., see Tsai, M.Y. 151, 519
Ehnholm, C., see Huuskonen, J. 151, 451
Ekstro¨m, M., see Huuskonen, J. 151, 451
Elliott, J., see Grieve, D.J. 151, 471
Ellison, R.C., see Tsai, M.Y. 151, 519
Eue, I., C. Langer, A. Eckardstein, C. Sorg, Myeloid related protein
Author index6ol.151 (2000)
602
Jacques, P.F., see Jenner, J.L. 151, 541
Jansen, M., see Schmaldienst, S. 151, 493 Jauhiainen, M., see Huuskonen, J. 151, 451
Jenner, J.L., P.F. Jacques, L.J. Seman, E.J. Schaefer, Ascorbic acid supplementation does not lower plasma lipoprotein(a) concentrations 151, 541
Jennings, G.L., see Ward, M.R. 151, 407 Kanellakis, P., see Ward, M.R. 151, 407
Karjalainen, A., J. Heikkinen, M.J. Savolainen, A.-C. Ba¨ckstro¨m, Y.A. Kesa¨niemi, Regulation of plasma low density lipoprotein levels in postmenopausal women 151, 559
Karjalainen, L., see Pihlajama¨ki, J. 151, 567
Kark, J.D., R. Sinnreich, E. Leitersdorf, Y. Friedlander, S. Shpitzen, G. Luc, Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol 151, 509
Kastelein, J.J.P., see Hoffer, M.J.V. 151, 443
Kesa¨niemi, Y.A., see Karjalainen, A. 151, 559
Kinoshita, M., see Kojima, S. 151, 585
Kojima, S., Y. Goto, H. Nonogi, H. Horie, M. Kinoshita, N. Iwai, Role of a p53 polymorphism in luminal narrowing after balloon coronary angioplasty 151, 585
Kristenson, M., C. Lassvik, B. Bergdahl, Z. Kucinskie`ne, L. Aizienie`ne, Z. Bo, L. Scha¨fer Elinder, A.G. Olsson, Ultrasound determined carotid and femoral atherosclerosis in Lithuanian and Swedish men: the LiVicordia study 151, 501
Kucinskie`ne, Z., see Kristenson, M. 151, 501
Kuusisto, J., see Pihlajama¨ki, J. 151, 567
Laakso, M., see Pihlajama¨ki, J. 151, 567
Landgren, F., see Nielsen, N.E. 151, 423 Langer, C., see Eue, I. 151, 593
Larson, I.A., see Sun, Z. 151, 381
Lassvik, C., see Kristenson, M. 151, 501
Latcham, J., see Grimsditch, D.C. 151, 389
Lau, Y.-T., see Hsieh, C.-C. 151, 481
Lehtonen-Veromaa, M., see Vasankari, T. 151, 399
Leino, A., see Vasankari, T. 151, 399
Leitersdorf, E., see Kark, J.D. 151, 509
Lindbohm, N., H. Gylling, T.E. Miettinen, T.A. Miettinen, Statin treatment increases the sialic acid content of LDL in hypercholesterolemic patients 151, 545
Lindgren, A., see Andersson, A. 151, 535
Lip, G.Y.H., see Belgore, F.M. 151, 599
Liu, H.-W., see Hsieh, C.-C. 151, 481
Luc, G., see Kark, J.D. 151, 509 Mancini, M., see Baldassarre, D. 151, 575 Manzato, E., see Arosio, M. 151, 551
Marklund, S.L., see Stra˚lin, P. 151, 433
Marmot, M., see Ishizaki, M. 151, 415
Martikainen, P., see Ishizaki, M. 151, 415
Ma¨rz, W., see Nauck, M.S. 151, 525 Mattern, D., see Nauck, M.S. 151, 525
Metso, J., see Huuskonen, J. 151, 451
Miettinen, R., see Pihlajama¨ki, J. 151, 567
Miettinen, T.A., see Lindbohm, N. 151, 545
Miettinen, T.E., see Lindbohm, N. 151, 545 Mo¨tto¨nen, T., see Vasankari, T. 151, 399
Mykka¨nen, L., see Pihlajama¨ki, J. 151, 567
Nakagawa, H., see Ishizaki, M. 151, 415
Nauck, M.A., see Nauck, M.S. 151, 525
Nauck, M.S., H. Scharnagl, H. Nissen, C. Schu¨rmann, D. Mattern, M.A. Nauck, H. Wieland, W. Ma¨rz, FH-Freiburg: a novel missense mutation (C317Y) in growth factor repeat A of the low
density lipoprotein receptor gene in a German patient with homozygous familial hypercholesterolemia 151, 525
Nielsen, N.E., L. Brattstro¨m, B. Hultberg, F. Landgren, E. Swahn, Plasma total homocysteine levels in postmenopausal women with unstable coronary artery disease 151, 423
Nissen, H., see Nauck, M.S. 151, 525
Nonogi, H., see Kojima, S. 151, 585
Olkkonen, V.M., see Huuskonen, J. 151, 451
Olsson, A.G., see Kristenson, M. 151, 501
Ordovas, J.M., see Sun, Z. 151, 381
Otto, C., P. Schwandt, More on atorvastatin and fibrinogen 151, 591
Penfold, S., see Grimsditch, D.C. 151, 389
Pihlajama¨ki, J., R. Miettinen, R. Valve, L. Karjalainen, L. Mykka¨nen, J. Kuusisto, S. Deeb, J. Auwerx, M. Laakso, The Pro12Ala substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia 151, 567
Pussinen, P., see Huuskonen, J. 151, 451 Ramsey, D., see Ward, M.R. 151, 407 Ricci, G., see Baldassarre, D. 151, 575 Rimondi, S., see Baldassarre, D. 151, 575
Ros, E., Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk 151, 357
Rossi, C.M., see Arosio, M. 151, 551 Sartore, G., see Arosio, M. 151, 551
Savolainen, M.J., see Karjalainen, A. 151, 559 Schaefer, E.J., see Jenner, J.L. 151, 541 Schaefer, E.J., see Sun, Z. 151, 381
Scha¨fer Elinder, L., see Kristenson, M. 151, 501 Scharnagl, H., see Nauck, M.S. 151, 525
Schmaldienst, S., S. Banyai, T.M. Stulnig, G. Heinz, M. Jansen, W.H. Ho¨rl, K. Derfler, Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia 151, 493
Schu¨rmann, C., see Nauck, M.S. 151, 525
Schwandt, P., see Otto, C. 151, 591
Seman, L.J., see Jenner, J.L. 151, 541
Shpitzen, S., see Kark, J.D. 151, 509
Sinnreich, R., see Kark, J.D. 151, 509
Sirtori, C.R., see Baldassarre, D. 151, 575
Snieder, H., see Hoffer, M.J.V. 151, 443
Sorg, C., see Eue, I. 151, 593
Stalenhoef, A.F.H., see Hoffer, M.J.V. 151, 443
Stra˚lin, P., S.L. Marklund, Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells 151, 433
Stulnig, T.M., see Schmaldienst, S. 151, 493
Sun, Z., I.A. Larson, J.M. Ordovas, J.R. Barnard, E.J. Schaefer, Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrations 151, 381
Swahn, E., see Nielsen, N.E. 151, 423
Tahvanainen, E., see Huuskonen, J. 151, 451
Tsai, M.Y., D.K. Arnett, J.H. Eckfeldt, R.R. Williams, R.C. Ellison, Plasma homocysteine and its association with carotid intimal-medial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study 151, 519
Tull, S.P., see Williams, J.C. 151, 463
Vainio, A., see Huuskonen, J. 151, 451
Author index6ol.151 (2000) 603
Vasankari, T., M. Lehtonen-Veromaa, T. Mo¨tto¨nen, M. Ahotupa, K. Irjala, O. Heinonen, A. Leino, J. Viikari, Reduced mildly oxidized LDL in young female athletes 151,
399
Veglia, F., see Baldassarre, D. 151, 575 Ventura, A., see Baldassarre, D. 151, 575 Vidgeon-Hart, M., see Grimsditch, D.C. 151, 389 Viikari, J., see Vasankari, T. 151, 399
Ward, M.R., P. Kanellakis, D. Ramsey, G.L. Jennings, A. Bobik,
Response to balloon injury is vascular bed specific: A consequence of de novo vessel structure? 151, 407
Wieland, H., see Nauck, M.S. 151, 525
Williams, J.C., M.D. Fotherby, L.A. Forster, S.P. Tull, G.A.A. Ferns, Mononuclear cell adhesion to collagen ex vivo is related to pulse pressure in elderly subjects 151, 463
